Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCP-001 in Acute Myeloid Leukemia
NCT01373515Phase 2Completed
- Sponsor
- Mendus
- Start
- Apr 2011
- Primary completion
- Feb 2013
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of vididencel in acute myeloid leukemia (AML), sponsored by Mendus. Started Apr 2011; status: completed.
02
Drugs
vididencel
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01373515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01373515.